Marko Jukic

Title: Marko Jukic: Innovator in Pharmaceutical Synthesis

Introduction

Marko Jukic is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes for the preparation of key intermediates for statins.

Latest Patents

Marko Jukic holds a patent titled "Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof." This invention relates to a commercially viable process for synthesizing key intermediates for the preparation of statins, specifically Rosuvastatin and Pitavastatin. The innovative approach presented in this patent offers a new, simple, and short synthetic route that utilizes inexpensive and readily available starting materials. Notably, this method avoids the conventional use of DIBAL-H as a reducing agent, enhancing the efficiency of the synthesis process.

Career Highlights

Marko Jukic is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His work at Lek Pharmaceuticals has allowed him to focus on innovative solutions that contribute to the advancement of drug synthesis and development.

Collaborations

Throughout his career, Marko has collaborated with esteemed colleagues, including Zdenko Casar and Damjan Sterk. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.

Conclusion

Marko Jukic's contributions to the field of pharmaceutical synthesis, particularly through his patented processes, highlight his role as an innovator in the industry. His work continues to influence the development of effective and efficient methods for synthesizing vital medications.